RESUMO
Poly (lactic acid) (PLA), due to its biodegradability, biocompatibility, and renewability, is one of the most promising biobased polymers for replacing some of the petrol-based materials. Low flexibility of PLA is overcome, by blending it with olefin-based polymers, such as polypropylene (PP). However, the use of compatibilizing agents is required to attain final materials with suitable mechanical properties. Such agents, although essential, can affect PLA structure and, consequently, the mechanical properties of the PLA. To the best of our knowledge, this issue was never studied, and the results can contribute to achieving the best formulations of PLA-based blends according to their final applications. The thermal and mechanical properties of the extruded PLA, with three different commercial compatibilizing agents, were evaluated with the purpose of demonstrating how the compatibilizers can introduce structural differences into the PLA chain during the extrusion process. The combination of crystallinity, molecular weight, and the morphology of the samples after extrusion determines the final mechanical properties of PLA. Despite being a fundamental study, it is our aim to contribute to the sustainability of PLA-based industries. The addition of a 2.5% concentration of C1 compatibilizer seems to have less influence on the final morphology and mechanical properties of the blends.
RESUMO
This paper reviews recent advances in graphene-based biosensors development in order to obtain smaller and more portable devices with better performance for earlier cancer detection. In fact, the potential of Graphene for sensitive detection and chemical/biological free-label applications results from its exceptional physicochemical properties such as high electrical and thermal conductivity, aspect-ratio, optical transparency and remarkable mechanical and chemical stability. Herein we start by providing a general overview of the types of graphene and its derivatives, briefly describing the synthesis procedure and main properties. It follows the reference to different routes to engineer the graphene surface for sensing applications with organic biomolecules and nanoparticles for the development of advanced biosensing platforms able to detect/quantify the characteristic cancer biomolecules in biological fluids or overexpressed on cancerous cells surface with elevated sensitivity, selectivity and stability. We then describe the application of graphene in optical imaging methods such as photoluminescence and Raman imaging, electrochemical sensors for enzymatic biosensing, DNA sensing, and immunosensing. The bioquantification of cancer biomarkers and cells is finally discussed, particularly electrochemical methods such as voltammetry and amperometry which are generally adopted transducing techniques for the development of graphene based sensors for biosensing due to their simplicity, high sensitivity and low-cost. To close, we discuss the major challenges that graphene based biosensors must overcome in order to reach the necessary standards for the early detection of cancer biomarkers by providing reliable information about the patient disease stage.